Cancer diagnostics - Keeping targeted therapy on target

John Garratt, Director of the Canadian Pathology Quality Assurance (CPQA)
September 30, 2021

About this webinar

This webinar, given by John Garratt, will cover how CPQA, Canadian Pathology Quality Assurance, assists labs to provide accurate biomarker testing by highlighting the breast cancer EQA program. In addition, the challenges of providing a quality assurance program for the newer biomarkers that are related to the latest drug therapies and the importance of collaborations will be presented.

About the presenters

John Garratt is a director of the Canadian Pathology Quality Assurance (CPQA) scheme which is a not for profit agency based in Vancouver, Canada. John was the Anatomic Pathology technical specialist at Vancouver Coastal Health when CPQA was first formed in 2008 and is now in semi retirement. In addition to a passion for all things pathology John enjoys long distance running and kayaking in Canada's beautiful west coast.

Scroll to Top